Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T14:15:52.195Z.
Calculation as of: 2026-10-06T14:15:52.195Z.
Quote observation: 2026-10-06T14:15:23.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8e18e4937bb179ad65bb801f5f057f36d78bd2e4af2c39ec5cecdad017acf428
EARNINGS YIELD
N/A
BriaCell Therapeutics Corp.
Market Cap
$35.58M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$33.24M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BriaCell Therapeutics Corp. (BCTX) | $35.58M | N/A | N/A | N/A | N/A |
| Elicio Therapeutics, Inc. (ELTX)vs › | $35.75M | N/A | N/A | N/A | N/A |
| Elutia Inc (ELUT)vs › | $35.82M | 116.01% | 90.36% | 90.36% | 90.36% |
| DocGo Inc. (DCGO)vs › | $36.38M | N/A | 6.97% | 4.38% | 4.29% |
| Accuray Incorporated (ARAY)vs › | $36.59M | N/A | 0.42% | 0.42% | 1.38% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.01M | N/A | N/A | N/A | N/A |
| HeartBeam, Inc. (BEAT)vs › | $33.53M | N/A | N/A | N/A | N/A |
| Edesa Biotech, Inc. (EDSA)vs › | $37.73M | N/A | N/A | N/A | N/A |
| EUDA Health Holdings Limited (EUDA)vs › | $33.24M | N/A | N/A | N/A | N/A |
| Aligos Therapeutics, Inc. (ALGS)vs › | $32.86M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
